Search for: "Pharmaceuticals USA, Inc." Results 21 - 40 of 917
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
12 Oct 2010, 9:59 pm by Patent Docs
§ 2201) in the Hatch-Waxman context in Teva Pharmaceuticals USA, Inc. v. [read post]
6 Aug 2014, 1:28 pm
Teva Pharmaceuticals USA, Inc. et al, the plaintiff alleged that metoclopramide, the generic name for Relgan, caused her to develop the neurologic condition known as tardive dyskinesia. [read post]
24 Feb 2009, 9:43 pm
Food and Drug Administration from approving the Abbreviated New Drug Application (ANDA) filed by Defendant-Appellant Teva Pharmaceuticals USA, Inc. [read post]
17 Oct 2018, 7:49 pm by Brian Craig
The Federal Circuit found the district court committed no error in construing claim terms as non-limiting for nonobviousness purposes or in invalidating as obvious all asserted claims of the Copaxone patents, including a 40-milligram dosage three times per week (Teva Pharmaceuticals USA, Inc. v. [read post]
7 Jun 2018, 4:59 pm by Patent Docs
Ltd.; Teva Pharmaceuticals International GMGH; and Teva Pharmaceuticals USA, Inc. [read post]
22 Jul 2018, 8:32 pm by Patent Docs
IPR2016-01127, IPR2016-01128, IPR2016-01129, IPR2016-01130, IPR2016-01131, and IPR2016-01132 (and parallel IPRs filed by Petitioners Teva Pharmaceuticals USA, Inc. and Akorn, Inc., which had... [read post]
23 Nov 2018, 8:03 pm by Patent Docs
Teva Pharmaceuticals USA Inc. case beginning at 4:00 pm (Eastern) on December 4, 2018 at the American University Washington College of Law in Washington, DC. [read post]
., Ltd. and HEC Pharm USA Inc., vacated its prior decision, and reversed the district court’s judgment that the claims of patent at issue were not invalid (Novartis Pharmaceuticals Corporation. v. [read post]
30 Aug 2020, 10:19 am by Ben Vernia
According to DOJ’s press release: The United States has filed a False Claims Act complaint against Teva Pharmaceuticals USA Inc. and Teva Neuroscience Inc. [read post]
13 Oct 2014, 8:46 pm by Patent Docs
Teva Pharmaceuticals USA, Inc. et al. v. [read post]
1 Sep 2015, 9:59 pm by Patent Docs
Patent No. 7,772,209, owned by Lilly, would be infringed by the ANDA products for which Defendants Teva Parenteral Medicines, Inc.; Teva Pharmaceuticals USA, Inc.; APP Pharmaceuticals, LLC; Barr Laboratories, Inc.; and Pliva Hrvatska D.O.O. sought approval to market (opinion).... [read post]
25 Aug 2008, 4:10 am
STMicroelectronics, Inc., Teva Pharmaceuticals USA, Inc. v. [read post]